Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | ANPEP | P15144 | 3/20 | 0.33 |
| ▸ | LAP3 | P28838 | 2/20 | 0.33 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.33 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.33 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.32 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.32 |
| ▸ | FDPS | P14324 | 2/20 | 0.31 |
| ▸ | MMP8 | P22894 | 2/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL701768 | 0.74 | — | — | |
| SCHEMBL27967901 | 0.74 | ALDH1A1 (0.48) | ALDH1A1TRPM8TDP1ANPEPLAP3 | |
| SCHEMBL6654979 | 0.70 | — | — | |
| SCHEMBL14146243 | 0.68 | LMNA (0.38) | ALDH1A1TRPM8TDP1ANPEPLAP3 | |
| SCHEMBL17488991 | 0.68 | LMNA (0.40) | GRM4FDPSMMP2 | |
| SCHEMBL10655372 | 0.68 | TRPM8 (0.52) | ALDH1A1TRPM8TDP1ANPEPLAP3 | |
| SCHEMBL5140906 | 0.67 | GABBR2 (0.56) | ALDH1A1GABBR2GABBR1FDPS | |
| SCHEMBL13291847 | 0.67 | LMNA (0.36) | ALDH1A1TRPM8TDP1ANPEPLAP3 | |
| SCHEMBL3941968 | 0.67 | GRM8 (0.38) | TDP1GRM4 | |
| SCHEMBL13057236 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10246640-B2 | Mixtures of at least one dialkylphosphinic acid with at least one other dialkylphosphinic acid that is different therefrom, method for production thereof, and use thereof | CLARIANT INTERNATIONAL LTD. (CH) | 2019-04-02 | — | — | US | disclosed |
| US-20180010047-A1 | Mixtures Of At Least One Dialkylphosphinic Acid With At Least One Other Dialkylphosphinic Acid That Is Different Therefrom, Method For Production Thereof, And Use Thereof | CLARIANT INTERNATIONAL LTD. (CH) | 2018-01-11 | — | — | US | disclosed |
| EP-2794623-B1 | MIXTURES OF AT LEAST ONE DIALKYLPHOSPHINIC ACID WITH AT LEAST ONE OTHER DIALKYLPHOSPHINIC ACID THAT IS DIFFERENT THEREFROM, METHOD FOR PRODUCTION THEREOF, AND USE THEREOF | CLARIANT INT LTD (CH) | 2017-10-18 | — | — | EP | disclosed |
| US-20140350149-A1 | Mixtures Of At Least One Dialkylphosphinic Acid With At Least One Other Dialkylphosphinic Acid That Is Different Therefrom, Method For Production Thereof, And Use Thereof | CLARIANT FINANCE (BVI) LIMITED (VG) | 2014-11-27 | — | — | US | disclosed |
| EP-2794623-A1 | MIXTURES OF AT LEAST ONE DIALKYLPHOSPHINIC ACID WITH AT LEAST ONE OTHER DIALKYLPHOSPHINIC ACID THAT IS DIFFERENT THEREFROM, METHOD FOR PRODUCTION THEREOF, AND USE THEREOF | Clariant Finance (BV) Limited (VG) | 2014-10-29 | — | — | EP | disclosed |
| WO-2013091805-A1 | MIXTURES OF AT LEAST ONE DIALKYLPHOSPHINIC ACID WITH AT LEAST ONE OTHER DIALKYLPHOSPHINIC ACID THAT IS DIFFERENT THEREFROM, METHOD FOR PRODUCTION THEREOF, AND USE THEREOF | CLARIANT INTERNATIONAL LTD (CH) | 2013-06-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10246640-B2 | Mixtures of at least one dialkylphosphinic acid with at least one other dialkylphosphinic acid that is different therefrom, method for production thereof, and use thereof | CYP27A1, CYP21A2, CYP46A1 | ALDH1A1 363/4885TRPM8 4683/4885TDP1 2975/4885 |
| US-20180010047-A1 | Mixtures Of At Least One Dialkylphosphinic Acid With At Least One Other Dialkylphosphinic Acid That Is Different Therefrom, Method For Production Thereof, And Use Thereof | CYP21A2, CYP27A1, CYP46A1 | ALDH1A1 418/4885TRPM8 4568/4885TDP1 3121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.